Evidence map›Paper›PMID 38959309›Full record

ArticleScience advances2024

nucMACC: An MNase-seq pipeline to identify structurally altered nucleosomes in the genome.

Sara Wernig-Zorc, Fabian Kugler, Leo Schmutterer, Patrick Räß, Clemens Hausmann, Simon Holzinger, Gernot Längst, Uwe Schwartz

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sara Wernig-ZorcRegensburg Center for Biochemistry (RCB), University of Regensburg, Regensburg, Germany.ORCID 0000-0002-4377-7982
Fabian KuglerRegensburg Center for Biochemistry (RCB), University of Regensburg, Regensburg, Germany.ORCID 0009-0004-5155-1192
Leo SchmuttererNGS Analysis Center Biology and Pre-clinical Medicine, University of Regensburg, Regensburg, Germany.ORCID 0009-0005-8846-3257
Patrick RäßNGS Analysis Center Biology and Pre-clinical Medicine, University of Regensburg, Regensburg, Germany.ORCID 0009-0009-8337-2443
Clemens HausmannNGS Analysis Center Biology and Pre-clinical Medicine, University of Regensburg, Regensburg, Germany.
Simon HolzingerRegensburg Center for Biochemistry (RCB), University of Regensburg, Regensburg, Germany.ORCID 0009-0003-0651-4563
Gernot LängstRegensburg Center for Biochemistry (RCB), University of Regensburg, Regensburg, Germany.ORCID 0000-0002-8232-1179
Uwe SchwartzNGS Analysis Center Biology and Pre-clinical Medicine, University of Regensburg, Regensburg, Germany.ORCID 0000-0002-7628-2687

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Micrococcal nuclease sequencing is the state-of-the-art method for determining chromatin structure and nucleosome positioning. Data analysis is complex due to the AT-dependent sequence bias of the endonuclease and the requirement for high sequencing depth. Here, we present the nucleosome-based MNase accessibility (nucMACC) pipeline unveiling the regulatory chromatin landscape by measuring nucleosome accessibility and stability. The nucMACC pipeline represents a systematic and genome-wide approach for detecting unstable ("fragile") nucleosomes. We have characterized the regulatory nucleosome landscape in

Indexed as

Drosophila melanogasterMicrococcal NucleaseNucleosomesSaccharomyces cerevisiaeAnimalsChromatinChromatin Assembly and DisassemblyGenomePromoter Regions, GeneticRNA Polymerase IISequence Analysis, DNAChromatinMicrococcal NucleaseNucleosomesRNA Polymerase II

Identifiers

PMID38959309
PMCPMC11221511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.